1
INTRODUCTION 16
Cryptococcus neoformans is a ubiquitous environmental fungus that causes pneumonia 17 and meningitis. This opportunistic pathogen infects over a million individuals each year, 18 with overall mortality exceeding 20% (1-3). Patient immune status is the main determinant 19 of infection outcome, highlighting the importance of efficient host immune responses in 20 the control of cryptococcosis. 21 C. neoformans infection begins when the organism is inhaled, followed by its proliferation 22 in the lungs. This pulmonary infection may then disseminate to the brain, where it causes 23 a frequently lethal meningoencephalitis. In the lungs, C. neoformans first interacts with 24 host macrophages and dendritic cells (DC). These can engulf the fungus and migrate to 25 draining lymph nodes, where they present antigen to T cells to initiate the adaptive im-26 mune response. The protective immune response to C. neoformans is primarily mediated 27 by T cells. Although T helper cell type 1 (Th1) responses are protective against C. neofor-28 mans (4), it is likely that T helper type 17 (Th17) responses participate in pathogen clear-29 ance at mucosal surfaces (5-7). In contrast, T helper cell type 2 (Th2) responses are 30 considered detrimental for protective immunity, leading to fungal growth and facilitating 31 dissemination to the CNS (8, 9) . The induction of these non-protective responses is not 32 well understood, but cryptococcal glycans may contribute to this process (10). 33
Glycan structures participate in antigen recognition, immune activation, or immune regu-34 lation in multiple organisms (11). In C. neoformans the major virulence factor, a polysac-35 charide capsule, modulates the immune response via multiple mechanisms (12, 13) . The 36 capsule is primarily composed of two large polysaccharides: glucuronoxylomannan 37 (GXM) and glucuronoxylomannogalactan (GXMGal) (14, 15). One major component of 38 both polymers is xylose (Xyl), which comprises almost one fourth of the polysaccharide 39 capsule mass (16) . Xylose also occurs in cryptococcal glycolipids (17) and as both Xyl 40 and Xyl-phosphate modifications of protein-linked glycans (18) (19) (20) . We demonstrate here 41 that Xyl plays a critical role in the immune recognition of, and response to, C. neoformans. 42
The incorporation of Xyl into cryptococcal glycan structures occurs in the lumen of the 43 secretory pathway, via enzymatic reactions that use the substrate molecule This xylose donor is imported into the synthetic compartment by two transporters, Uxt1 45 and Uxt2 (21). A mutant strain that lacks both transporters (uxt1Δ uxt2Δ) exhibits defects 46 in glycosylation, including incomplete synthesis of capsule polysaccharides, and consid-47 erable attenuation of virulence in mouse models of infection. Surprisingly, despite its com-48 promised virulence, this attenuated strain persists in the lungs of infected mice. In pursu-49 ing the mechanism of this persistence, we observed the formation of inducible bronchus 50 associated lymphoid tissue (iBALT) in the lungs of both wild-type (WT) and uxt1Δ uxt2Δ 51 infected mice. In the lungs of mice infected with the mutant strain, iBALT formation was 52 significantly delayed. However, once formed, it was better organized than the iBALT 53 formed when mice were infected with fully xylosylated WT C. neoformans. Furthermore, 54 animals infected with the mutant experienced a long-term asymptomatic infection rather 55 than the rapid and lethal disease observed upon WT infection. Together, these results 56 suggest that luminal Xyl modifications of cryptococcal glycoconjugates interfere with im-57 mune recognition and activation of immune cells, events that are required for efficient 58 control of the pulmonary infection. 59
RESULTS

61
UDP-Xyl transport is required for cryptococcal virulence and dissemination 62
We previously observed that a C. neoformans strain lacking UDP-Xyl transporters (uxt1Δ 63 uxt2Δ) was highly attenuated in virulence compared to the WT parental strain KN99α, yet 64 persisted in the lungs of asymptomatic mice for at least 100 days after infection (21). To 65 investigate the development of this chronic infection, we first examined the kinetics of 66 fungal burden in mice after intranasal inoculation with WT and mutant strains. In A/JCr 67 mice infected intranasally with WT fungi, which typically succumb to infection roughly 18 68 days post-infection (dpi), we observed a rapid and significant increase in pulmonary fun-69 gal burden ( Fig 1A) along with significant dissemination to the spleen ( Fig 1B) and brain 70 ( Fig 1C) . In contrast, the pulmonary burden in uxt1Δ uxt2Δ-infected mice increased only 71 gradually from initial inoculum levels to a modest peak at 63 dpi ( Fig 1A) . Colony-forming 72 units in the lung then gradually declined, with complete clearance occurring in 30% of the 73 mice by 189 dpi (Fig 1A) . Although this infection was not limited to the lungs, only a frac-74 tion of the mice had measurable uxt1Δ uxt2Δ cells in the spleen ( Fig 1B) and brain (Fig 75 1C) at 63 dpi. Furthermore, this limited dissemination was only observed at the times of 76 highest lung burden (63 and 126 dpi), with no fungi detected at distal sites by 189 dpi (Fig  77   1B , Fig 1C) . These results suggest that the A/JCr mice would eventually clear the uxt1Δ 78 uxt2Δ infection. 79 80 Cryptococcal xylosylation influences differential production of pulmonary cytokines. 81
We next sought to identify the mechanism(s) responsible for the protracted host clearance 82 of uxt1Δ uxt2Δ infection. As summarized above, protection against C. neoformans is gen-83 erally associated with production of type 1 cytokines like interleukin (IL)-2, IL-12, inter-84 feron gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α). In contrast, a Th2 re-85 sponse to cryptococcal infection (characterized by the production of IL-4, IL-5, IL-10, and 86 IL-13) compromises control of pulmonary fungal burden (22) and facilitates dissemination 87 to the central nervous system (4, 22). 88
89
We hypothesized that the increased survival of mice infected with the mutant cryptococci 90 reflected an alteration in the immune response elicited by pulmonary infection. To test 91 this hypothesis, we analyzed cytokine levels over time in lung homogenates from mice 92 infected with WT or uxt1Δ uxt2Δ strains (Fig 1) . A strong Th2-type response with signifi-93 cant induction of IL-4 and IL-5 over the 15 days prior to sacrifice was detected in mice 94 infected with WT cryptococci (Fig 1D, Fig 1E) . In contrast, uxt1Δ uxt2Δ cells elicited a 95 more quiescent cytokine response at early stages of infection. Furthermore, at the peak 96 of fungal burden in uxt1Δ uxt2Δ-infected mice (day 63, Fig. 1A ), there was a significant 97 increase in the Th1 polarizing cytokine IL-12p40 compared to the levels observed in naïve 98 lungs ( Fig 1F) . Subsequently, IL-12p40 levels slowly declined, along with fungal burden 99 ( Fig 1F) . Although levels of IFNg and TNFa ( Fig 1G, Fig 1H) were similar to those in the 100 lungs of naïve mice, IL-17 trended higher at the peak of infection ( Fig 1I) . Overall, while 101 WT infection rapidly induced non-protective Th2 responses, infection with uxt1Δ uxt2Δ 102 failed to do so (even at the peak of fungal burden) and instead promoted the sustained 103 induction of IL-12p40 and increased production of IL-17. 104
Inducible bronchus-associated lymphoid tissue develops following cryptococcal infection 106
The differences that we observed in fungal burden and cytokine levels between mutant 107 and WT infection suggested alterations in the immune response at the cellular level. To 108 test this, we performed blinded morphometric analysis of inflammatory cell infiltration in 109 the lungs at 15 dpi in mice infected with WT fungi and at 15 and 189 dpi in uxt1Δ uxt2Δ-110 infected mice. The animals infected with the mutant strain showed significantly reduced 111 lung inflammation at both time points (Fig 2A) , consistent with the more quiescent cyto-112 kine response reported above (Fig 1) . We also noted distinctive lymphocytic accumula-113 tions proximal to the basal side of the bronchial epithelium in both groups of mice (Fig  114   2B ). The lymphoid populations within these structures were organized into B cell follicles 115 surrounded by CD3 + T cell cuffs ( Fig 2C) . The cellular composition of these inflammatory 116 foci suggested inducible bronchus-associated lymphoid tissue (iBALT) (23). 117 118 iBALT is a tertiary lymphoid tissue that forms in the lung. It resembles secondary lymphoid 119 organs (lymph nodes) in cellular composition and organization, with two distinctive zones: 120 the B cell follicle and the T cell zone (24). The B cell follicle contains mainly follicular B 121 cells and its organization is maintained by the continuous production of CXCL13. It is 122 surrounded by a T cell zone that contains CD4 and CD8 T cells as well as dendritic cells 123 (DCs) (25). At 15 dpi with WT cryptococci, we observed numerous iBALT structures, with 124 compact B cell follicles surrounded by T cells (Fig 2C, Fig 2D) . In contrast, we found 125 considerably fewer and less organized B cell follicles at 15 dpi in mice infected with the 126 uxt1Δ uxt2Δ strain ( Fig 2C, Fig 2D) . By late in infection (189 dpi for uxt1Δ uxt2Δ and 15 127 dpi for WT), although iBALT structures in mice infected with the mutant strain were still 128 less abundant than those found in lungs of WT ( Fig. 2D ), their average size was signifi-129 cantly larger ( Fig. 2E ). Additionally, the iBALT was more organized and even contained 130 IgG + plasma cells ( Fig 2C) . Early in uxt1Δ uxt2Δ infection, the compromised formation of 131 iBALT structures was accompanied by increased peri-vascular accumulation of T cells 132 ( Fig. 2F ) and a significantly decreased production of CXCL13 ( Fig 2G, Fig2H) , a chemo-133 kine essential for iBALT formation and organization (23). In contrast, at late time points 134 in this protracted developmental process, T cell cuffing was significantly reduced ( Fig 
Survival of uxt1Δ uxt2Δ-infected mice is dependent on T cells 149
To test the protective role of T and B cells in the prolonged survival of uxt1Δ uxt2Δ-in-150 fected mice, we examined whether ablation of these cell types altered the course of in-151 fection. Because the mouse strains used for these studies were engineered in the 152 C57BL/6 background, we included infections of this strain as controls. C57BL/6 mice are 153 less resistant to C. neoformans than A/JCr mice used above (26), as shown by their even-154 tual susceptibility to uxt1Δ uxt2Δ infection ( Fig. 3D , solid black line). In contrast, Rag1-/-155 mice were significantly more susceptible to this strain, and succumbed by 55 dpi ( sons, we wished to specifically measure DC responses. To do this we tested DC interac-177 tions with WT cryptococcal cells, which exhibit antigens modified with Xyl, and uxt1Δ 178 uxt2Δ cryptococci, which are impaired in these modifications. We also tested single uxtΔ 179 mutants: uxt1Δ shows an intermediate level of Xyl utilization while uxt2Δ is similar to WT 180 (21). In these assays, we measured the ability of heat-killed fungi to stimulate the produc-181 tion of pro-inflammatory cytokines by DC, comparing WT, uxt1Δ uxt2Δ, single uxt mu-182 tants, uxs1Δ (which lacks all Xyl modification because it cannot synthesize UDP-Xyl), and 183 an acapsular control strain (cap59Δ) that induces a potent DC response (29). We found 184 that bone marrow derived DCs (BMDCs) cultured with uxt1Δ uxt2Δ cells released high 185 levels of IL-1β, IL-6, and TNF-α, similar to the levels observed following exposure to a 186 completely acapsular control strain, cap59Δ (Fig 4A-C) . In contrast, individual uxt mutants 187 and uxs1Δ induced IL-1b and IL-6 levels similar to those induced by WT fungi (close to 188 background levels; Fig 4A, Fig 4B) . TNF-α similarly showed the greatest response upon 189 challenge with uxt1Δ uxt2Δ, with levels like those induced by an acapsular strain, alt-190 hough some increase was also noted with other xylose-deficient strains (uxt1Δ and 191 uxs1Δ). These results suggest that early interaction with DCs and consequent induction 192 of proinflammatory cytokines are regulated by Xyl expression in Cryptococcus. 193 194 DISCUSSION 195 In this study, we report for the first time that C. neoformans infection triggers iBALT for-196 mation. Notably, the iBALT detected in our experimental infections resembles subpleural 197 nodules that have been observed in cryptococcosis patients (30). To our knowledge, the 198 only other fungus reported to induce iBALT is Pneumocystis (31). Further examination 199 will be necessary to establish the similarities between histological features of inflamma-200 tory cell infiltration in mice and humans infected with C. neoformans and to delineate the 201 molecular host-pathogen interactions that drive iBALT formation following C. neoformans 202 infection. 203
204
When we infected mice with mutant fungi unable to use Xyl for luminal glycoconjugate 205 synthesis (uxt1Δ uxt2Δ), we observed a delay in fungal accumulation and in the organi-206 zation of the iBALT structures. When uxt1Δ uxt2Δ burden did peak, it was accompanied 207 by a rise in IL-12p40 ( Fig 1F) , a cytokine normally required for inducing a protective re-208 sponse against C. neoformans (32), which may have facilitated subsequent resolution 209 of the uxt1Δ uxt2Δ infection. A change in IL-12p40 level might reflect an increase in ei-210 ther IL-23 or IL-12 (33), which stimulate a Th17 or Th1 type response, respectively; the 211 former is required for iBALT formation(31). Since we saw no difference in IFN-γ levels, 212 IL-12p40 is more likely associated with a Th17 response. We did observe a trend to-213 wards increased IL-17 levels when uxt1Δ uxt2Δ burden was the highest, which was ab-214 sent in WT infection. Our results show that cryptococcal infection can induce iBALT 215 structures, although this does not prevent mice from succumbing to the disease. We fur-216 ther show that the kinetics of iBALT formation and its organization are dependent on vir-217 ulence factors of the pathogen. Future studies should futher define the functional role of 218 iBALT in mediating immunity to Cryptococcus and determine whether the iBALT is me-219 diating early and local immune protection in the lung. 220 221 DCs reacted more strongly to uxt1Δ uxt2Δ than to WT in vitro, releasing greater amounts 222 of pro-inflammatory cytokines (Fig 4A-C) , even though the global cytokine response to 223 the mutant is less perturbed (Fig 1D-I) . These cytokines may directly or indirectly lead to 224 the increased recruitment of T and B cells in uxt1Δ uxt2Δ infection (Fig 3A-C) and perhaps 225 accelerate compartmentalization into compact B cell follicles and discrete T cell areas in 226 iBALT (Fig 2) . Such differences in cellular composition and organization, coupled with the 227 differences in the local cytokine production, may confer distinct properties on the iBALT 228 induced by WT and uxt1Δ uxt2Δ, influencing their ability to protect against C. neoformans. 229
230
We expected that the highly immunostimulatory behavior of uxt1Δ uxt2Δ in vitro reflected 231 the lack of Xyl modifications on its surface glycoconjugates, a consequence of the ab-232 sence of UDP-Xyl transport into the secretory compartment. We were surprised, there-233 fore, that mutants unable to synthesize UDP-Xyl (uxs1Δ), which similarly lack Xyl modifi-234 cations on secreted glycoconjugates, did not phenocopy this broad and robust DC re-235 sponse. This suggests that Uxs1 itself is required for the strong response seen in the 236 absence of xylosylation in the secretory pathway. It may be that this protein plays addi-237 tional roles unrelated to glycosylation, or that the stimulatory component is dependent on 238 cytosolic UDP-Xyl, rather than UDP-Xyl that has been transported into the secretory path-239 way. 240 Unlike encapsulated strains, C. neoformans mutants lacking capsule induce the upregu-242 lation of multiple genes involved in cytokine responses and enhance antigen processing 243 and presentation by DCs (34). Interestingly, the cytokine levels induced in DC by the 244 uxt1Δ uxt2Δ mutant were similar to those induced by the acapsular mutant cap59Δ ( (Fig 3D) , which suggests that 261 iBALT formation may play a key role in restricting disease. Even in the absence of T and 262 B cells, however, mutant-infected mice still survived more than twice as long as WT-in-263 fected animals ( Fig 3D) . This may be due to the slightly slower growth of the mutant, 264 which we have previously observed (21). 265 266 We have found that C. neoformans infection induces iBALT formation, although the for-267 mation of iBALT by itself is insufficient to protect against wild-type fungal infection. Inoc-268 ulation with a uxt1Δ uxt2Δ strain, however, induced similar lymphoid structures, which do 269 appear to restrict infection despite their delayed organization. In vitro, this mutant induced 270 DCs to release much higher levels of proinflammatory cytokines than WT fungi. This is 271 presumably a consequence of the lack of surface Xyl modification, suggesting a role for 272 this structure in the immunosuppressive features of capsule polysaccharides or other sur-273 face exposed or secreted glycoconjugates, although the full mechanism remains to be 274 defined. By influencing the dynamics of the inflammatory process, we may be able to 275 improve pulmonary responses to help control infection and use this information to help 276 guide novel therapies that stimulate the induction of protective lung fungal immunity. 277
278
MATERIALS AND METHODS 279
Fungal strains 280 C. neoformans strains (Table S1) Mice were intranasally inoculated with a 50 µL aliquot, and then weighed and monitored 304 daily. Infected mice were sacrificed if they lost >20% relative to peak weight or at specified 305 time points. At the time of sacrifice, mice were perfused intracardially with 10 mL sterile 306 PBS, and organs were processed as described below for fungal burden, histology, flow 307 cytometric analysis, and cytokine measurements. 308
Organ burden and cytokines 310
Brain and spleen homogenates were harvested and plated for CFU at the specified time 311 points. 50 μL aliquots of the left lung homogenates (VT = 1 mL) were similarly plated for 312
CFUs. The remaining sample was assayed for pulmonary cytokine levels using the Bio-313
Plex Protein Array System (Bio-Rad Laboratories). Briefly, the lung homogenates were 314 mixed with an equal volume of PBS/0.1% Triton 100x/2x protease inhibitor (Pierce EDTA-315 free protease inhibitor; Thermo Scientific), vortexed for 3 seconds, and clarified by cen-316 trifugation (2500 x g, 10 min). Supernatant fractions were then assayed using the Bio-317
Plex Pro Mouse Cytokine 23-Plex (Bio-Rad Laboratories) for the presence of IL-1α, IL-318 1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17A, granulo-319 cyte colony stimulating factor (G-CSF), granulocyte monocyte colony stimulating factor 320 The right lung of individual mice was enzymatically digested (in 5 mL RPMI with 1 mg/mL 339 collagenase type IV) at 37 °C with shaking (230 rpm) for 30 min, and then sequentially 340 passed through sterile 70 and 40 µm pore nylon strainers (BD Biosciences, San Jose, 341 CA). Red blood cells in the samples were lysed by treatment for 3 min on ice with 5 mL 342 ammonium-chloride-potassium lysing buffer (8.024 g/L NH4Cl, 1.001 g/L KHCO3, 2.722 343 mg/L EDTANa2 2H2O), followed by the addition of 2 volumes of PBS. The remaining cells 344 were pelleted (1000 x g, 5 min, 4 °C), washed twice with PBS, diluted to 10 6 cells/mL in 345 PBS, and stained with LIVE/DEAD fixable blue dead cell stain (1:1000; Thermo Scien-346 tific). Following incubation in the dark for 30 min at 4 °C, cells were washed with PBS and 347 FACS buffer (2% fetal bovine serum in PBS) before resuspension in FACS buffer. Sam-348 ples were then blocked with CD16/CD32 (1:500; Fc Block™; BD Biosciences, RRID: 349 AB_394656) for 5 min and incubated for 30 min with optimal concentrations of fluoro-350 chrome-conjugated antibodies (Table S2) 
Isolation of bone marrow derived cells 359
Bone marrow was flushed from the femurs and tibiae of C57BL/6 mice using RPMI. Cells 360 were collected (1000 x g, 5 min, 4°C), resuspended in RPMI, and counted using a hemo-361 cytometer. To prepare bone marrow derived dendritic cells (BMDCs), 2 x 10 6 bone mar-362 row cells were plated in 10 mL R10 medium (10% FBS, 0.4% Penicillin-Streptomycin, 2 363 mM L-glutamate, 50 μM 2-β-mercaptoethanol in RPMI) supplemented with 1 ng/mL GM-364 CSF, and incubated at 37 °C and 5% CO2. Medium was changed 3 and 6 days after 365 plating, and cells were harvested on day 8. BMDCs were enriched by depletion of BMMs 366 using biotinylated α-F4/80 antibody (eBioscience, RRID: AB_466657) and anti-biotin con-367 jugated magnetic beads (Miltenyi Biotec). The BMDCs in the flow through were positively 368 selected using α-CD11c magnetic beads according to the manufacturer's protocol (Mil-369 tenyi Biotec). 370
371
Dendritic cell assays 372
To assay the ability of fungal strains to activate BMDCs, C. neoformans strains of interest 373 were grown O/N, washed in PBS, and incubated at 65 °C for 15 min to heat kill (HK) the 374 fungi. BMDCs and HK fungi (10 6 cells of each) were then co-incubated for 24 h, sedi-375 mented, and the supernatant fractions transferred to 1.5 mL centrifuge tubes containing 376 10 μL of 100x protease inhibitor (ThermoScientific). IL-1β, IL-6, and TNF-α levels in su-377 pernatants were determined by ELISA according to the manufacturer's protocol (R&D 378 systems). 379 380
Statistical analysis 381
Each experiment was performed a minimum of two times. Statistical analyses were con-382 ducted using GraphPad Prism version 6.0f (GraphPad Software). All studies comparing 383 two groups were analyzed with a Student's t-test. Those with three or more groups were 384 compared using an ordinary one-way ANOVA with Tukey's post-hoc test. p < 0.05 was 385 considered statistically significant. Survival of mice after intranasal inoculation with 5 × 10 4 cells of WT (n = 5) or uxt1Δ uxt2Δ (n = 10). Results shown are combined from two independent experiments. **, p < 0.01; ***, p < 0.005 by the log-rank test. Figure 4 . Cytokine production by dendritic cells stimulated with cryptococcal antigens. DCs were co-incubated for 24 h with heat-killed cells of the strains indicated or subjected to no treatment (no tx). Levels of (B) IL-1β, (C) IL-6, and (D) TNF-α in the supernatant were quantified by ELISA. Data shown is the mean ± SD (n = 3) of one representative experiment from five independent experiments that yielded similar results. **, p < 0.01 by one-way ANOVA with Tukey's post hoc test.
